In addition the relationship between ROS, BCL2 and cell-cycle status for the different normal and leukemic SPC subsets requires further clarification in order to understand the relationship between emergence of SPCs with potential chemo-resistant functional properties and maturation stage in both CD34+ and more mature CD34− AML subtypes. This evidence concerns the gene BCL2 and acute myeloid leukemia.